Keryx Biopharmaceuticals (NASDAQ: KERX) ANALYSIS OF PERFORMANCES IN FOCUS:
The company has achieved revenue of $ 94218,000. Revenue is also referred to as sales or turnover. Some companies receive interest income, royalties or other fees. Revenue can refer to business income in general, or may refer to the amount, in a monetary unit, earned over a period of time. The company's net income is $ -90838000. Net income available to common stockholders equals net income minus the privileged dividends paid. The net profits available to the common shareholders are the remaining profits after the company pays all its suppliers, employees, service providers, creditors and preferred shareholders. In other words, it's all revenue minus all your favorite expenses and dividends. The number measures the credit of the common shareholders on the company's cash flows.
Keryx Biopharmaceuticals (NASDAQ: KERX) made about 18.309859% last month and achieved 4.024768% in the last quarter. The stock showed a return of -74.173713% over five years and recorded a weekly return of 0%. The stock was seen at -25.663717% return over the last twelve months.
By monitoring the last 52 weeks, the high price of the 52-week shares was observed at $ 5.98 and the 52-week low seen at $ 2.47. The 50 SMA is $ 3.046667 and 200 SMA is $ 3.522263. Moving averages can be used as support or resistance when a trader looks for a possible entry or exit on the market. This can also be said in the following way. In the event that the price makes a contact with the moving average on the price table, the trader, examining this chart carefully, will enter a long position or a short position. In reality, this works the same way as horizontal support or resistance lines. Moving averages are known as dynamic support and resistance, simply because they tend to change with prices.
Keryx Biopharmaceuticals (NASDAQ: KERX) the stock changed $ 0.19 and moved 5.99% while the share price hit $ 3.36 in the last commercial transaction (Monday). 2596031 shares traded by hand while it is an average volume with 1069882 shares. The company recorded the relative volume of 2.43. When an analyst or investor is looking for a stock, it's good to know what other investors think of it. After all, they might have some more information about the company or they could create a trend. The most popular methods for assessing the market's opinion is to look at the recently traded volume.
Analyst recommended a consensus score of 2.6 on this stock. Analysts also expected the stock to reach the share value at $ 5.5 in the next one-year period. EBITDA is $ -87626000. EBITDA is the income of a company before interest, taxes, depreciation and amortization and is an accounting measure calculated using the net profits of a company, before interest charges, taxes, amortization and depreciation are deducted as a proxy for profitability current of a company.
The return on invested capital (ROCE) is -93.58%. Return on investment (ROCE) is a financial report that measures the profitability of a company and the efficiency with which its capital is used. The return on invested capital (ROCE) is the total amount of capital that a company has used to generate profits. It is the sum of the net assets and liabilities of the debt. It can be simplified as a total of assets minus current liabilities.
The current ratio is 2.214. The current relationship is the classic measure of liquidity. Indicates if the company can pay the debts due within one year from current assets. The quick report is 0.976. 1: 1 shows that the company can meet its current financial obligations with quick funds at hand. A ratio of less than 1: 1 could indicate that the company relies too much on inventory or other assets to pay off its short-term liabilities.
The debt / equity shows a value of 1394.778. The D / E ratio is calculated by dividing the total liabilities of a company by its own share capital. In general, a high debt / capital ratio means that a company may not be able to generate enough money to meet its debt obligations. However, low debt / capital ratios may also indicate that a company is not exploiting the greater profits that leverage can bring.
The volatility or the average percentage of the real interval (ATRP 14) is 4.76%. The ATR expressed as a percentage of the closing price. The average of the real interval percentage (ATRP) measures volatility at a relative level. ATRP allows you to compare titles while ATR no. This means that low-priced shares will not necessarily have lower ATR values than higher-priced ones. The beta value of the shares was seen at 2.137070. Beta measures the amount of market risk associated with market trading. The high beta reveals more riskiness and the low beta shows a low risk.
Monitoring of the control of profitability, of the company profit margin which was recorded at -96.41% and operating margin recorded at -94.04%. The company maintained a gross margin of 37.80%. The institutional property of the company is equal to 75.22%, while the insider's property is equal to 1.50%. The Company has been able to maintain the return on business (ROA) of -34.01% in the last twelve months. Return on equity (ROE) recorded at -49081.08%.
Headquarters The Keryx Biopharmaceuticals office (NASDAQ: KERX) is United States. Forward P / E is standing at -21. The Forward P / E is a measure of the price / earnings ratio using the expected earnings for the P / E calculation for the next fiscal year. The stock has PEG of -0.04. PEG ratio used to determine the value of a security taking into account the growth in earnings. The P / S ratio of 4.292846 reflects the value of sales on the market. The P / B ratio is 67.73333. P / B is used to compare the market value of a security with its book value. It has a market capitalization of $ 404463360. Using market capitalization to show the size of a company is important because the size of the company is a basic determinant of various characteristics in which investors are interested, including the risk .
Now the company has an RSI figure of 61.11. The RSI compares the entity of recent gains with recent losses to see if an asset is oversold or overbought. RSI is plotted on a scale of 0 to 100. Generally, if it is above 70, the stock is considered overbought and then you can try to sell it. Similarly, an RSI below 30 indicates that the stock is oversold and can be purchased.
ADX value listed in 21.78. ADX is best used for inventory screening and writing scans. By adding this indicator to the scanning software, it is possible to eliminate all the stocks that are in the trading ranges. You can then set the scan to find only stocks with a sharp uptrend or strong downtrend.
So what is the ADX indicator for?
The ADX indicator does not provide signals of purchase or sale. However, it gives you some perspective on where the title is in the trend. Low readings and you have a trading interval or the beginning of a trend. Extremely high readings indicate that the trend will probably end.
Larry Spivey – Category – Business
Larry Spivey it also covers economic news in all market sectors. He also has a huge knowledge of the stock market. He holds an MBA degree from the University of Florida. He has more than 10 years experience in writing financial and market news. Previously, Larry has worked in several companies with different roles including web developer, software engineer and product manager. Currently it deals with the Business news section.